Osteoporosis Treatment
Infusion & Injectable Therapies for Stronger Bones
What Is Osteoporosis?
Osteoporosis is a chronic, progressive bone disease that leads to decreased bone mass, deterioration of bone structure, and an increased risk of fractures. It is often called a “silent disease” because there are usually no symptoms until a fracture occurs. Fractures from osteoporosis—especially of the hip, spine, and wrist—can cause significant pain, disability, and loss of independence. With effective prevention and treatment, fracture risk can be reduced and bone strength improved.
How Bone Loss Happens
Bone is constantly being broken down and rebuilt. In osteoporosis, resorption (breakdown by osteoclasts) outpaces formation (by osteoblasts), so more bone is lost than replaced. Estrogen deficiency after menopause, aging, certain medications (e.g., glucocorticoids), and other factors accelerate this imbalance.
Who Is at Risk?
Risk factors include age (especially over 50), female sex, family history of osteoporosis or hip fracture, small body frame, low calcium and vitamin D intake, sedentary lifestyle, smoking, excessive alcohol, and long-term use of corticosteroids or some other medications. Osteoporosis can also be secondary to other conditions (e.g., rheumatoid arthritis, diabetes, chronic kidney disease). Diagnosis is often made by bone mineral density (BMD) testing (DXA scan), with a T-score of −2.5 or lower defining osteoporosis; clinical risk tools such as FRAX help estimate 10-year fracture risk.
Treatment Goals
The main goal is to prevent fractures by improving bone strength and reducing bone loss. Management includes adequate calcium and vitamin D, weight-bearing and muscle-strengthening exercise, fall prevention, and—when fracture risk is elevated—medication. For many patients, oral bisphosphonates are first-line, but infusion and injectable therapies offer important alternatives: better adherence (less frequent dosing), fewer gastrointestinal side effects, and in some cases greater efficacy. They are especially valuable for those who cannot tolerate oral agents or who are at high or very high fracture risk.
Infusion & Injectable Therapies We Offer
CarePoint Infusion Center provides office-based administration of leading osteoporosis medications. Below is an overview of the main infusion and injectable options.
The “Big Three” Infusion/Injection Options
Comparison of administration and mechanism.
Evenity (Romosozumab) – Monthly for 12 Months
A sclerostin inhibitor with a dual mechanism: it increases bone formation and decreases resorption. Given as two subcutaneous injections monthly for 12 months (210 mg total per month). Produces rapid, substantial BMD gains and strong vertebral fracture risk reduction. Use is limited to 12 months; patients should then transition to an antiresorptive (e.g., Prolia or bisphosphonate) to maintain gains. Carries a boxed warning for cardiovascular risk and should not be started in patients with recent heart attack or stroke. See our Evenity (Romosozumab) page for details.
Prolia (Denosumab) – Twice-Yearly Injection
A RANKL inhibitor given as 60 mg subcutaneous injection every 6 months. It strongly reduces bone resorption and is not cleared by the kidneys, so it can be used in many patients with chronic kidney disease. Reduces vertebral and hip fracture risk significantly; BMD continues to improve with long-term use. Important: Doses must be given on time; stopping without transitioning to another antiresorptive can cause rapid bone loss and rebound vertebral fractures. Learn more in our Prolia (Denosumab) guide.
Reclast (Zoledronic Acid) – Yearly IV Infusion
A potent bisphosphonate given as a once-yearly 5 mg IV infusion (at least 15 minutes). It inhibits osteoclast-mediated bone resorption, reducing vertebral fractures by about 70% and hip fractures by about 41% in clinical trials. Ideal for patients who prefer annual dosing or cannot tolerate oral bisphosphonates. Pre-infusion hydration and acetaminophen can reduce flu-like acute-phase reactions. Not for use in severe renal impairment (CrCl < 35 mL/min).
Other options (e.g., teriparatide, abaloparatide, IV ibandronate) may be used in specific situations and are typically coordinated with or referred by your physician.
Quick Comparison
| Medication | Class | Frequency | Route | Key Point |
|---|---|---|---|---|
| Reclast | Bisphosphonate | Once yearly | IV infusion | Annual dosing; avoid if CrCl < 35 |
| Prolia | RANKL inhibitor | Every 6 months | Subcutaneous | Do not stop without transition |
| Evenity | Sclerostin inhibitor | Monthly × 12 months | Subcutaneous | Then switch to antiresorptive; CV warning |
Change in Bone Density
Average percentage increase in Bone Mineral Density (BMD) at the Lumbar Spine over 12 months.
Lifestyle & Bone Health
Adequate calcium (1,000–1,200 mg/day) and vitamin D (800–1,000 IU/day), weight-bearing and muscle-strengthening exercise, and fall prevention support bone health and complement medication. For more on non-drug interventions, see our Non-Pharmacological Bone Health page.
Serving Northeast Ohio Communities
CarePoint Infusion Center is your trusted provider for infusion therapy throughout Northeast Ohio. As leading providers in the region, we're conveniently located to serve patients from Cleveland and Beachwood to communities throughout Cuyahoga County. Whether you're searching for "osteoporosis treatment near me" in Cleveland, "bone density treatment Beachwood OH", or infusion and injectable osteoporosis care anywhere in Northeast Ohio, we're here to help.
We conveniently serve patients from:
And throughout Cuyahoga County and Northeast Ohio. Contact us today to schedule your osteoporosis infusion or injection appointment in Beachwood or Cleveland, Ohio.
Take the Next Step
If you or a loved one is considering infusion or injectable osteoporosis therapy, our team can provide a comfortable, supervised setting and coordinate with your referring provider. We offer pre-treatment assessment, patient education, and follow-up monitoring.
Contact us:
- Phone: 216-755-4044
- Fax: 330-967-0571
- Address: 23215 Commerce Park Suite 318, Beachwood, OH 44122
- Hours: Monday–Friday, 9:00 AM – 5:00 PM
Visit our Contact page to send a message or request an appointment.
Additional Resources
- Prolia (Denosumab) – Biannual injection for osteoporosis
- Evenity (Romosozumab) – 12-month anabolic therapy
- Non-Pharmacological Bone Health – Nutrition, exercise, fall prevention
- All Infusion Services – Conditions we treat and therapies we offer
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice. Treatment decisions must be made with a qualified healthcare provider based on your individual situation. Always consult your doctor for diagnosis and treatment of osteoporosis.